KLRK1 and neoplasm: NKG2D blocking inhibited lysis of MIC+ or ULBP+ IEC lines (or of MICA-transfected tumor cell lines) by IL-15-primed human effector CTL, suggesting that upregulation of NKG2D on CTL converts them into potent killers (18).